Nutrition in adult and childhood cancer: Role of carcinogens and anti-carcinogens

Anticancer Research

Volumn 32, Issue 10, 2012, Pages 4171-4192

  Mosby, Terezie T ^a   Cosgrove, Maeve ^a   Sarkardei, Samiramis ^a   Platt, Karl L ^b   Kaina, Bernd ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cancer prevention; Cancer risk factors; Carcinogens; Childhood cancer; Diet; Nutrition; Oncology; Review

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; AFLATOXIN B1; ALCOHOL; ANTIOXIDANT; AROMATIC AMINE; BENZENE DERIVATIVE; CALCIUM; CARBOHYDRATE; CARCINOGEN; CYTOCHROME P450; DRINKING WATER; FLAVONOID; HEME; HETEROCYCLIC AMINE; MONOCROTALINE; MYCOTOXIN; NITROSO DERIVATIVE; OCHRATOXIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON; POLYUNSATURATED FATTY ACID; PYRROLIZIDINE ALKALOID; QUINOLINE DERIVATIVE; SODIUM; SUGAR; TANNIN; VITAMIN; VITAMIN D;

ADULT; ADULTHOOD; ALCOHOL CONSUMPTION; BODY MASS; BODY WEIGHT; BREAST FEEDING; CALCIUM INTAKE; CALORIC RESTRICTION; CANCER PREVENTION; CARBOHYDRATE INTAKE; CEREAL; CHEMICAL CARCINOGENESIS; CHILD; CHILD NUTRITION; CHILDHOOD CANCER; COOKING; DAIRY PRODUCT; DIET SUPPLEMENTATION; DIETARY FIBER; DNA DAMAGE; EATING HABIT; EGG; FAT INTAKE; FISH; FOOD CONTAMINATION; FOOD PROCESSING; FRUIT; GRAIN; GROUPS BY AGE; HERB; HUMAN; INDUCED MUTATION; LEGUME; LIPID PEROXIDATION; LOW FAT DIET; MATERNAL NUTRITION; METABOLIC ACTIVATION; MILK; MUTAGENICITY; NEOPLASM; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PHYSICAL ACTIVITY; POULTRY; PREGNANCY; PRIORITY JOURNAL; PYROLYSIS; RED MEAT; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SODIUM INTAKE; SPICE; VEGETABLE; VITAMIN INTAKE;

ADOLESCENT; ADULT; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; DIET; FEMALE; HUMANS; MALE; NEOPLASMS; RISK; YOUNG ADULT;

EID: 84867755367     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (216)

1. Heron M: Deaths: Leading causes for 2007, National Vital Statistics Reports, Vol. 59, Hyattsville, MD, U.S.A., National Center for Health Statistics, 2011.
2. World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC, U.S.A., American Institute for Cancer Research, 2007.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
4. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA and Edwards BK: Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103: 714-736, 2011.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
6. American Cancer Society. Cancer Facts & Figures 2011. Atlanta, GA, U.S.A., American Cancer Society, 2011.
7. SEER Cancer Statistics Review, 1975-2008. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Chen H, Feuer E, Cronin K and Edwards B (eds.). Bethesda, MD, U.S.A., National Cancer Institute, 2011. Retrieved from http://seer.cancer.gov/ csr/1975-2008/
8. World Cancer Research Fund/American Institute for Cancer Research: Policy and Action for Cancer Prevention. Food, Nutrition, and Physical Activity: a Global Perspective. Washington, DC, U.S.A., American Institute for Cancer Research, 2009.
9. Cross AJ, Ferrucci LM, Risch A, Graubard BI, Ward MH, Park Y, Hollenbeck AR, Schatzkin A and Sinha R: A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res 70: 2406-2414, 2010.
10. English DR, MacInnis RJ, Hodge AM, Hopper JL, Haydon AM and Giles GG: Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 13: 1509-1514, 2004. (Pubitemid 39202319)
11. Bastide NM, Pierre FH and Corpet DE: Heme iron from meat and risk of colorectal cancer: A meta-analysis and a review of the mechanisms involved. Cancer Prev Res 4: 177-184, 2011.
12. Pierre F, Freeman A, Tache S, Van der Meer R and Corpet DE: Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr 134: 2711-2716, 2004. (Pubitemid 39315277)
13. Lee DH, Anderson KE, Harnack LJ, Folsom AR and Jacobs DR, Jr.: Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst 96:403-407, 2004. (Pubitemid 38351302)
14. Bartsch H and Montesano R: Relevance of nitrosamines to human cancer. Carcinogenesis 5: 1381-1393, 1984. (Pubitemid 15218943)
15. Holder CL, Preece SW, Conway SC, Pu YM and Doerge DR: Quantification of heterocyclic amine carcinogens in cooked meats using isotope dilution liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 11: 1667-1672, 1997. (Pubitemid 27451454)
16. Busquets R, Puignou L, Galceran MT and Skog K: Effect of red wine marinades on the formation of heterocyclic amines in fried chicken breast. J Agric Food Chem 54: 8376-8384, 2006. (Pubitemid 44785429)
17. Melo A, Viegas O, Petisca C, Pinho O and Ferreira IM: Effect of beer/red wine marinades on the formation of heterocyclic aromatic amines in pan-fried beef. J Agric Food Chem 56:10625-10632, 2008.
18. Nagao M, Wakabayashi K, Ushijima T, Toyota M, Totsuka Y and Sugimura T: Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals. Environ Health Perspect 104(Suppl 3): 497-501, 1996. (Pubitemid 26196393)
19. Oda Y, Aryal P, Terashita T, Gillam EMJ, Guengerich FP and Shimada T: Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase. Mutat Res 492: 81-90, 2001. (Pubitemid 32480273)
20. Butler MA, Iwasaki M, Guengerich FP and Kadlubar FF: Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86: 7696-7700, 1989. (Pubitemid 19265255)
21. Snyderwine EG, Venugopal M and Yu M: Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat Res 506-507: 145-152, 2002. (Pubitemid 35286549)
22. Knize MG, Salmon CP, Pais P and Felton JS: Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagens/carcinogens. Adv Exp Med Biol 459: 179-193, 1999.
23. Ramesh A, Walker SA, Hood DB, Guillen MD, Schneider K and Weyand EH: Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol 23:301-333, 2004. (Pubitemid 39451824)
24. Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, Niaz MS and Ramesh A: Polycyclic aromatic hydrocarbons and digestive tract cancers - a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 29:324-357, 2011.
25. van Maanen JM, Moonen EJ, Maas LM, Kleinjans JC and van Schooten FJ: Formation of aromatic DNA adducts in white blood cells in relation to urinary excretion of 1-hydroxypyrene during consumption of grilled meat. Carcinogenesis 15: 2263-2268, 1994. (Pubitemid 24317490)
26. Tareke E, Rydberg P, Karlsson P, Eriksson S and Tornqvist M: Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50: 4998-5006, 2002. (Pubitemid 34856181)
27. Acrylamide. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Industrial Chemicals, Vol. 60. Lyon, France, World Health Organization. International Agency for Research on Cancer, pp. 389-433, 1994.
28. Dybing E and Sanner T: Risk assessment of acrylamide in foods. Toxicol Sci 75: 7-15, 2003. (Pubitemid 37098730)
29. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR and Chan JM: Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr 91: 712-721, 2010.
30. Bissonauth V, Shatenstein B and Ghadirian P: Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview. Cancer Detect Prev 32: 52-64, 2008.
31. Bandera EV, Kushi LH, Moore DF, Gifkins DM and McCullough ML: Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis. Cancer Cause Control 18: 967-988, 2007. (Pubitemid 47241092)
32. Robertson DJ, Sandler RS, Haile R, Tosteson TD, Greenberg ER, Grau M and Baron JA: Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol 100: 2789-2795, 2005.
33. Eggs. In: The World's Healthiest Foods. George Mateljan Foundation, 2012. Retrieved from http://www.whfoods.com/genpage.php?tname=foodspice&dbid= 92#safetyissues
34. Applegate E: Nutritional and functional roles of eggs in the diet. J Am Coll Nutr 19: 495S-498S, 2000.
35. Detopoulou P, Panagiotakos DB, Antonopoulou S, Pitsavos C and Stefanadis C: Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. Am J Clin Nutr 87: 424-430, 2008. (Pubitemid 351226080)
36. Caubet JC and Wang J: Current understanding of egg allergy. Pediatr Clin North Am 58: 427-443, 2011.
37. Xu X, Gammon MD, Zeisel SH, Lee YL, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM and Chen J: Choline metabolism and risk of breast cancer in a population-based study. FASEB J 22: 2045-2052, 2008. (Pubitemid 351811480)
38. Yokoyama S, Sells MA, Reddy TV and Lombardi B: Hepatocarcinogenic and promoting action of a choline-devoid diet in the rat. Cancer Res 45: 2834-2842, 1985. (Pubitemid 15232758)
39. da Costa KA, Niculescu MD, Craciunescu CN, Fischer LM and Zeisel SH: Choline deficiency increases lymphocyte apoptosis and DNA damage in humans. Am J Clin Nutr 84: 88-94, 2006. (Pubitemid 44699175)
40. Making sense of foods: Understanding the problems with dairy products. Nutrition MD by the Physicians Committee for Responsible Medicine (PCRM). Retrieved from http://www.nutritionmd.org/nutrition-tips/nutrition-tips- understand-foods/dairy.html
41. Kesteloot H, Lesaffre E and Joossens JV: Dairy fat, saturated animal fat, and cancer risk. Prev Med 20: 226-236, 1991.
42. Cho E, Spiegelman D, Hunter DJ, Chen WY, Stampfer MJ, Colditz GA and Willett WC: Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 95: 1079-1085, 2003. (Pubitemid 36950112)
43. Larsson SC, Bergkvist L and Wolk A: Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 80: 1353-1357, 2004.
44. Ganmaa D, Cui X, Feskanich D, Hankinson SE and Willett WC: Milk, dairy intake and risk of endometrial cancer: a 26-year follow-up. Int J Cancer 130: 2664-2671, 2012.
45. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E and Norat T: Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 23: 37-45, 2012.
46. Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E and Norat T: Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343: d6617, 2011.
47. Marlett JA, McBurney MI and Slavin JL: Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 102: 993-1000, 2002. (Pubitemid 40434172)
48. Chan AT and Giovannucci EL: Primary prevention of colorectal cancer. Gastroenterology 138: 2029-2043, 2010.
49. Chatenoud L, La Vecchia C, Franceschi S, Tavani A, Jacobs DR, Jr., Parpinel MT, Soler M and Negri E: Refined-cereal intake and risk of selected cancers in Italy. Am J Clin Nutr 70: 1107-1110, 1999.
50. Mueller NT, Odegaard A, Anderson K, Yuan JM, Gross M, Koh WP and Pereira MA: Soft drink and juice consumption and risk of pancreatic cancer: The Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 19: 447-455, 2010.
51. Interim Summary of Conclusions and Dietary Recommendations on Total Fat & Fatty Acids from the Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition, 10-14 November, 2008, WHO, Geneva, CH. Retrieved from http:// www.who.int/nutrition/topics/FFA-summary-rec-conclusion.pdf
52. Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm RA, Graham S, Howe GR, Kushi LH, Marshall JR, McDermott A, Miller AB, Speizer FE, Wolk A, Yaun SS and Willett WC: Cohort studies of fat intake and the risk of breast cancer - a pooled analysis. N Engl J Med 334: 356-361, 1996. (Pubitemid 26049588)
53. Smith-Warner SA, Spiegelman D, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Kushi LH, Miller AB, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A and Hunter DJ: Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 92: 767-774, 2001. (Pubitemid 32385723)
54. Dahm CC, Keogh RH, Lentjes MA, Spencer EA, Key TJ, Greenwood DC, Cade JE, Burley VJ, Shipley MJ, Brunner EJ, Stephen AM, Mishra G, Kuh D, Fentiman IS, White IR, Luben R, Khaw KT and Rodwell Bingham SA: Intake of dietary fats and colorectal cancer risk: prospective findings from the UK Dietary Cohort Consortium. Cancer Epidemiol 34: 562-567, 2010.
55. Armstrong B and Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15: 617-631, 1975.
56. Boyd NF, Martin LJ, Noffel M, Lockwood GA and Trichler DL: A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 68: 627-636, 1993. (Pubitemid 23258474)
57. Smith-Warner SA and Stampfer MJ: Fat intake and breast cancer revisited. J Natl Cancer Inst 99: 418-419, 2007. (Pubitemid 47073564)
58. Hopkins GJ and Carroll KK: Relationship between amount and type of dietary fat in promotion of mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 62: 1009-1012, 1979. (Pubitemid 9174370)
59. Hopkins GJ, Kennedy TG and Carroll KK: Polyunsaturated fatty acids as promoters of mammary carcinogenesis induced in Sprague-Dawley rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 66: 517-522, 1981. (Pubitemid 11098553)
60. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG and Gluud C: Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. In: The Cochrane Library prepared by The Cochrane Collaboration, Hoboken, NJ, U.S.A., John Wiley & Sons, pp. 1-235, 2010.
61. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035, 1994.
62. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr., Baker LH and Coltman CA Jr.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Amer Med Assoc 301: 39-51, 2009.
63. Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 201: 3-23, 1990.
64. Voskuil DW, Vrieling A, van't Veer LJ, Kampman E and Rookus MA: The insulin-like growth factor system in cancer prevention: Potential of dietary intervention strategies. Cancer Epidemiol Biomarkers Prev 14: 195-203, 2005. (Pubitemid 40165303)
65. Gnagnarella P, Gandini S, La Vecchia C and Maisonneuve P: Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87: 1793-1801, 2008. (Pubitemid 351872644)
66. Marsh K and Brand-Miller J: Glycemic index, obesity, and chronic disease. Am J Lifestyle Med 2: 142-150, 2008.
67. Freedland SJ and Aronson WJ: Dietary intervention strategies to modulate prostate cancer risk and prognosis. Curr Opin Urol 19:263-267, 2009.
68. Silvera SA, Rohan TE, Jain M, Terry PD, Howe GR and Miller AB: Glycaemic index, glycaemic load and risk of endometrial cancer: a prospective cohort study. Public Health Nutr 8: 912-919, 2005. (Pubitemid 41719158)
69. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL and Woodward M: The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence. Int J Cancer 125: 171-180, 2009.
70. Lof M and Weiderpass E: Impact of diet on breast cancer risk. Curr Opin Obstet Gynecol 21: 80-85, 2009.
71. Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X, Haile RW, Boice JD Jr. and Bernstein JL: Alcohol intake and cigarette smoking and risk of a contralateral breast cancer. The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol 169: 962-968, 2009.
72. León-Buitimea A, Rodríguez-Fragoso L, Lauer FT, Bowles H, Thompson TA and Burchiel SW: Ethanol-induced oxidative stress is associated with EGF receptor phosphorylation in MCF-10A cells overexpressing CYP2E1. Toxicol Lett 209: 161-165, 2012.
73. Seitz HK and Cho CH: Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol 472: 217-241, 2009.
74. Philip M, Rowley DA and Schreiber H: Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14: 433-439, 2004. (Pubitemid 39360991)
75. Yu HS, Oyama T, Isse T, Kitagawa K, Pham TT, Tanaka M and Kawamoto T: Formation of acetaldehyde-derived DNA adducts due to alcohol exposure. Chem Biol Interact 188: 367-375, 2010.
76. Hori K, Miyamoto S, Yukawa Y, Muto M, Chiba T and Matsuda T: Stability of acetaldehyde-derived DNA adduct in vitro.Biochem Biophys Res Commun 423: 642-646, 2012.
77. Archer VE and Jones DW: Capsaicin pepper, cancer and ethnicity. Med Hypotheses 59: 450-457, 2002.
78. Morris RD, Audet AM, Angelillo IF, Chalmers TC and Mosteller F: Chlorination, chlorination by-products, and cancer: A meta-analysis. Am J Public Health 82: 955-963, 1992.
79. Villanueva CM, Fernandez F, Malats N, Grimalt JO and Kogevinas M: Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health 57: 166-173, 2003. (Pubitemid 36250177)
80. Takahashi K, Akiniwa K and Narita K: Regression analysis of cancer incidence rates and water fluoride in the U.S.A. based on IACR/IARC (WHO) data (1978-1992). International Agency for Research on Cancer. J Epidemiol 11: 170-179, 2001. (Pubitemid 33798363)
81. Richardson SD, Plewa MJ, Wagner ED, Schoeny R and DeMarini DM: Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: A review and roadmap for research. Mutat Res 636: 178-242, 2007. (Pubitemid 350130339)
82. Clapp RW, Jacobs MM and Loechler EL: Environmental and occupational causes of cancer: New evidence 2005-2007. Rev Environ Health 23: 1-37, 2008. (Pubitemid 351644506)
83. Wogan GN: Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 52: 2114s-2118s, 1992.
84. Liu Y and Wu F: Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environ Health Perspect 118: 818-824, 2010.
85. Reggiani G and Bruppacher R: Symptoms, signs and findings in humans exposed to PCBs and their derivatives. Environ Health Perspect 60: 225-232, 1985. (Pubitemid 15038905)
86. Porta M and Zumeta E: Implementing the Stockholm Treaty on Persistent Organic Pollutants. Occup Environ Med 59: 651-652, 2002. (Pubitemid 35216499)
87. Larsen JC: Risk assessments of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in food. Mol Nutr Food Res 50: 885-896, 2006.
88. Polychlorinated dibenzo-para-dioxins. In: IARC Monographs on the evaluation of carcinogenic risks to humans: Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans, Vol. 69. Lyon, France, World Health Organization. International Agency for Research on Cancer, pp. 33-343, 1997.
89. Bernard A, Broeckaert F, De Poorter G, De Cock A, Hermans C, Saegerman C and Houins G: The Belgian PCB/dioxin incident: Analysis of the food chain contamination and health risk evaluation. Environ Res 88: 1-18, 2002. (Pubitemid 34136735)
90. Knerr S and Schrenk D: Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p- dioxin in experimental models. Mol Nutr Food Res 50: 897-907, 2006. (Pubitemid 44621795)
91. Tuomisto J and Tuomisto JT: Is the fear of dioxin cancer more harmful than dioxin? Toxicol Lett 210: 338-344, 2012.
92. Polednak AP: Trends in incidence rates for obesity-associated cancers in the US. Cancer Detect Prev 27: 415-421, 2003.
93. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003. (Pubitemid 36459468)
94. Obesity and overweight. Fact sheet no. 311. Media centre. World Health Organization, 2012. Retrieved from http://www.who.int/mediacentre/factsheets/ fs311/en/
95. Cutting calories: Cutting cancer risk. In: AICR ScienceNow 32. Washington, DC, U.S.A., American Institute for Cancer Research, 2010. Retrieved from http://preventcancer.aicr.org/site/DocServer/ScienceNow32.pdf?docID=3721
96. Papa V, Costantino A and Belfiore A: Insulin receptor - What role in breast cancer? Trends Endocrin Met 8: 306-312, 1997. (Pubitemid 27516732)
97. Key TJ, Appleby PN, Spencer EA, Travis RC, Roddam AW and Allen NE: Cancer incidence in vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford). Am J Clin Nutr 89: 1620S-1626S, 2009.
98. Singh PN, Sabate J and Fraser GE: Does low meat consumption increase life expectancy in humans? Am J Clin Nutr 78: 526S-532S, 2003. (Pubitemid 40012545)
99. Ginter E: Vegetarian diets, chronic diseases and longevity. Bratisl Lek Listy 109: 463-466, 2008.
100. McCarty MF, Barroso-Aranda J and Contreras F: The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. Med Hypotheses 72: 125-128, 2009.
101. Chicken. In: The World's Healthiest Foods. George Mateljan Foundation, 2012. Retrieved from http://www.whfoods.com/genpage.php?tname= foodspice&dbid=116#healthbenefits
102. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M and Wylie-Rosett J: Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 114: 82-96, 2006. (Pubitemid 44305278)
103. Bougnoux P: n-3 Polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 2: 121-126, 1999.
104. Hall MN, Chavarro JE, Lee IM, Willett WC and Ma J: A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 17: 1136-1143, 2008.
105. Gonzalez CA: The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 9: 124-126, 2006.
106. Pot GK, Geelen A, Majsak-Newman G, Harvey LJ, Nagengast FM, Witteman BJ, van de Meeberg PC, Hart AR, Schaafsma G, Lund EK, Rijkers GT and Kampman E: Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies. J Nutr 140: 371-376, 2010.
107. Calvo MS, Whiting SJ and Barton CN: Vitamin D intake: A global perspective of current status. J Nutr 135: 310-316, 2005. (Pubitemid 40194498)
108. Pufulete M: Intake of dairy products and risk of colorectal neoplasia. Nutr Res Rev 21: 56-67, 2008.
109. Egan KM: Vitamin D and melanoma. Ann Epidemiol 19: 455-461, 2009.
110. Lönnerdal B: Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 12: 293-297, 2009.
111. Shrier I, Szilagyi A and Correa JA: Impact of lactose containing foods and the genetics of lactase on diseases: an analytical review of population data. Nutr Cancer 60: 292-300, 2008. (Pubitemid 351601365)
112. Mathers JC: Pulses and carcinogenesis: potential for the prevention of colon, breast and other cancers. Br J Nutr 88(Suppl 3): S273-S279, 2002.
113. Dagnelie PC, Schuurman AG, Goldbohm RA and van den Brandt PA: Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93: 1139-1150, 2004. (Pubitemid 38746211)
114. Messina MJ: Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 70: 439S-450S, 1999.
115. Halvorsen BL, Holte K, Myhrstad MC, Barikmo I, Hvattum E, Remberg SF, Wold AB, Haffner K, Baugerod H, Andersen LF, Moskaug O, Jacobs DR Jr. and Blomhoff R: A systematic screening of total antioxidants in dietary plants. J Nutr 132: 461-471, 2002. (Pubitemid 34208750)
116. La Vecchia C: Association between Mediterranean dietary patterns and cancer risk. Nutr Rev 67(Suppl 1): S126-S129, 2009.
117. Freeman HJ: Adult celiac disease and its malignant complications. Gut Liver 3: 237-246, 2009.
118. Donini LM, Savina C and Cannella C: Nutrition in the elderly: role of fiber. Arch Gerontol Geriatr 49(Suppl 1): 61-69, 2009.
119. Fernandez E, Gallus S and La Vecchia C: Nutrition and cancer risk: an overview. J Br Menopause Soc 12: 139-142, 2006. (Pubitemid 46017599)
120. Garavello W, Lucenteforte E, Bosetti C and La Vecchia C: The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol 58: 25-34, 2009.
121. Silberstein JL and Parsons JK: Evidence-based principles of bladder cancer and diet. Urology 75: 340-346, 2010.
122. Paterson J, Baxter G, Lawrence J and Duthie G: Is there a role for dietary salicylates in health? Proc Nutr Soc 65: 93-96, 2006. (Pubitemid 43259988)
123. Bosetti C, Pelucchi C and La Vecchia C: Diet and cancer in Mediterranean countries: carbohydrates and fats. Public Health Nutr 12: 1595-1600, 2009.
124. Hanf V and Gonder U: Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk. Eur J Obstet Gynecol Reprod Biol 123: 139-149, 2005. (Pubitemid 41728356)
125. Escrich E, Moral R, Grau L, Costa I and Solanas M: Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res 51: 1279-1292, 2007. (Pubitemid 350013175)
126. Bougnoux P, Giraudeau B and Couet C: Diet, cancer, and the lipidome. Cancer Epidemiol Biomarkers Prev 15: 416-421, 2006.
127. Lewis NM, Seburg S and Flanagan NL: Enriched eggs as a source of n-3 polyunsaturated fatty acids for humans. Poult Sci 79: 971-974, 2000.
128. Berquin IM, Edwards IJ and Chen YQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269: 363-377, 2008.
129. Stanley JC, Elsom RL, Calder PC, Griffin BA, Harris WS, Jebb SA, Lovegrove JA, Moore CS, Riemersma RA and Sanders TA: UK Food Standards Agency Workshop Report: the effects of the dietary n-6:n -3 fatty acid ratio on cardiovascular health. Br J Nutr 98: 1305-1310, 2007. (Pubitemid 350193800)
130. Welsch CW: Relationship between dietary fat and experimental mammary tumorigenesis: A review and critique. Cancer Res 52:2040s-2048s, 1992.
131. Halliwell B and Gutteridge JMC: Free Radicals in Biology and Medicine, 4th ed., New York City, NY, U.S.A., Oxford University Press, 2007.
132. Tudek B, Winczura A, Janik J, Siomek A, Foksinski M and Olinski R: Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res 2: 254-284, 2010.
133. Kryston TB, Georgiev AB, Pissis P and Georgakilas AG: Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 711: 193-201, 2011.
134. Cao G, Alessio HM and Cutler RG: Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 14: 303-311, 1993. (Pubitemid 23066371)
135. Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods, Release 2 (2010). Nutrient Data Laboratory of the United States Department of Agriculture. Agricultural Research Service, 2012. Retrieved from http://www.ars.usda.gov/ Services/docs.htm? docid=15866
136. Scalbert A, Manach C, Morand C, Remesy C and Jimenez L: Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45: 287-306, 2005. (Pubitemid 41657352)
137. Tabassum A, Bristow RG and Venkateswaran V: Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing? Cancer Treat Rev 36: 230-234, 2010.
138. Tomita LY, Longatto Filho A, Costa MC, Andreoli MA, Villa LL, Franco EL and Cardoso MA: Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women. Int J Cancer 126: 703-714, 2010.
139. Krishnan AV, Trump DL, Johnson CS and Feldman D: The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am 39: 401-418, 2010.
140. Garland CF, French CB, Baggerly LL and Heaney RP: Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 31:607-611, 2011.
141. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007.
142. Gallagher ML: Vitamins. In: Krause's Food, Nutrition, and Diet Therapy, 11th ed. Mahan LK and Escott-Stump S (eds.), Philadelphia, PA, U.S.A., Saunders/Elsevier, pp. 75-119, 2004.
143. Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, Kohn N, Martinello S, Berkowitz R and Holick MF: Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 460: 213-217, 2007. (Pubitemid 46613793)
144. Moan J, Porojnicu AC, Dahlback A and Setlow RB: Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci USA 105: 668-673, 2008. (Pubitemid 351171766)
145. Whitney E and Rolfes SR: Water and the Major Minerals. In:Understanding Nutrition, 11th ed., Belmont, CA, U.S.A., Thomson Higher Education, pp. 396-439, 2008.
146. Ju J, Picinich SC, Yang Z, Zhao Y, Suh N, Kong AN and Yang CS: Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 31: 533-542, 2010.
147. Franceschi S, Bidoli E, Negri E, Zambon P, Talamini R, Ruol A, Parpinel M, Levi F, Simonato L and La Vecchia C: Role of macronutrients, vitamins and minerals in the aetiology of squamous-cell carcinoma of the oesophagus. Int J Cancer 86:626-631, 2000. (Pubitemid 30249871)
148. Bidoli E, Talamini R, Zucchetto A, Bosetti C, Negri E, Lenardon O, Maso LD, Polesel J, Montella M, Franceschi S, Serraino D and La Vecchia C: Dietary vitamins E and C and prostate cancer risk. Acta Oncol 48: 890-894, 2009.
149. Cameron E and Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 73: 3685-3689, 1976.
150. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J and Frytak S: Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 301: 687-690, 1979. (Pubitemid 10240445)
151. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ and Ames MM: High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 312: 137-141, 1985. (Pubitemid 15192859)
152. Herbert V, Shaw S and Jayatilleke E: Vitamin C-driven free radical generation from iron. J Nutr 126: 1213S-1220S, 1996. (Pubitemid 26105661)
153. Folate. In: The World's Healthiest Foods. George Mateljan Foundation, 2012. Retrieved from: http://www.whfoods.org/genpage.php?tname= nutrient&dbid=63
154. Thompson JR, Gerald PF, Willoughby ML and Armstrong BK: Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358: 1935-1940, 2001. (Pubitemid 34072874)
155. Linabery AM, Johnson KJ and Ross JA: Childhood cancer incidence trends in association with US Folic Acid Fortification (1986-2008). Pediatrics 129: 1125-1133, 2012.
156. Charles D, Ness AR, Campbell D, Davey Smith G and Hall MH: Taking folate in pregnancy and risk of maternal breast cancer. BMJ 329: 1375-1376, 2004. (Pubitemid 39656357)
157. Micke O, Schomburg L, Buentzel J, Kisters K and Muecke R: Selenium in oncology: From chemistry to clinics. Molecules 14:3975-3988, 2009.
158. Soni MG, Thurmond TS, Miller ER, 3rd, Spriggs T, Bendich A and Omaye ST: Safety of vitamins and minerals: Controversies and perspective. Toxicol Sci 118: 348-355, 2010.
159. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S and Horneber
160. Siddiqui IA, Saleem M, Adhami VM, Asim M and Mukhtar H: Tea beverage in chemoprevention and chemotherapy of prostate cancer. Acta Pharmacol Sin 28: 1392-1408, 2007. (Pubitemid 47366690)
161. Zhou F, Zhou H, Wang T, Mu Y, Wu B, Guo DL, Zhang XM and Wu Y: Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Acta Pharmacol Sin 33: 120-126, 2012.
162. Doss MX, Potta SP, Hescheler J and Sachinidis A: Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. J Nutr Biochem 16: 259-266, 2005. (Pubitemid 41556913)
163. Khan N, Afaq F, Saleem M, Ahmad N and Mukhtar H: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66: 2500-2505, 2006.
164. Yuan JH, Li YQ and Yang XY: Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice. Pharmacology 80: 269-278, 2007.
165. Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP and Zhang CH: (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol 13: 1162-1169, 2007. (Pubitemid 46592955)
166. Katiyar S, Elmets CA and Katiyar SK: Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem 18: 287-296, 2007. (Pubitemid 46590717)
167. Fujiki H, Suganuma M, Imai K and Nakachi K: Green tea: cancer preventive beverage and/or drug. Cancer Lett 188: 9-13, 2002. (Pubitemid 35292323)
168. Nagle DG, Ferreira D and Zhou YD: Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 67: 1849-1855, 2006. (Pubitemid 44291411)
169. Lambert JD, Sang S, Hong J, Kwon SJ, Lee MJ, Ho CT and Yang CS: Peracetylation as a means of enhancing in vitrobioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab Dispos 34: 2111-2116, 2006. (Pubitemid 44837773)
170. Landis-Piwowar K, Chen D, Chan TH and Dou QP: Inhibition of catechol-O-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol Rep 24: 563-569, 2010.
171. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E and Fujiki H: Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 59: 44-47, 1999. (Pubitemid 29062952)
172. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H and Fujiki H: Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771-1776, 1998. (Pubitemid 28476352)
173. Shim JH, Su ZY, Chae JI, Kim DJ, Zhu F, Ma WY, Bode AM, Yang CS and Dong Z: Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prev Res 3: 670-679, 2010.
174. Ermakova S, Choi BY, Choi HS, Kang BS, Bode AM and Dong Z: The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem 280: 16882-16890, 2005. (Pubitemid 41389147)
175. Kaefer CM and Milner JA: The role of herbs and spices in cancer prevention. J Nutr Biochem 19: 347-361, 2008. (Pubitemid 351689086)
176. Srivastava V, Negi AS, Kumar JK, Gupta MM and Khanuja SP: Plant-based anticancer molecules: A chemical and biological profile of some important leads. Bioorg Med Chem 13: 5892-5908, 2005. (Pubitemid 41399898)
177. Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES and Wang MB: Curcumin treatment suppresses IKKβ kinase activityof salivary cells of patients with head and neck cancer: A pilot study. Clin Cancer Res 17: 5953-5961, 2011.
178. Kim HI, Huang H, Cheepala S, Huang S and Chung J: Curcumin inhibition of integrin (α6β4)-dependent breast cancercell motility and invasion. Cancer Prev Res 1: 385-391, 2008.
179. Zhuang W, Long L, Zheng B, Ji W, Yang N, Zhang Q and Liang Z: Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 103: 684-690, 2012.
180. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K and McKenna SL: Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101: 1585-1595, 2009.
181. Amin A, Hamza AA, Bajbouj K, Ashraf SS and Daoud S: Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 54: 857-867, 2011.
182. Tavakkol-Afshari J, Brook A and Mousavi SH: Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol 46: 3443-3447, 2008.
183. Mousavi SH, Tavakkol-Afshari J, Brook A and Jafari-Anarkooli I: Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol 47: 1909-1913, 2009.
184. Samarghandian S, Boskabady MH and Davoodi S: Use of invitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line. Pharmacogn Mag 6: 309-314, 2010.
185. Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S, Van Veldhuizen P, Campbell DR and Banerjee SK: Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther 8: 315-323, 2009.
186. Cui W, Gu F and Hu KQ: Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 15: 1943-1950, 2009.
187. Ho YC, Liu CH, Chen CN, Duan KJ and Lin MT: Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines. Phytother Res 22:1465-1468, 2008. (Pubitemid 352789614)
188. Srivastava JK and Gupta S: Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 55: 9470-9478, 2007. (Pubitemid 350205299)
189. Yin QH, Yan FX, Zu XY, Wu YH, Wu XP, Liao MC, Deng SW, Yin LL and Zhuang YZ: Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 64: 43-51, 2012.
190. Sancheti G and Goyal PK: Effect of Rosmarinus officinalis in modulating 7,12-dimethylbenz(a)anthracene induced skin tumorigenesis in mice. Phytother Res 20: 981-986, 2006. (Pubitemid 44763784)
191. Yesil-Celiktas O, Sevimli C, Bedir E and Vardar-Sukan F: Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr 65: 158-163, 2010.
192. Johnson JJ, Syed DN, Heren CR, Suh Y, Adhami VM and Mukhtar H: Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5′-AMP-activated protein kinase (AMPK) pathway. Pharm Res 25: 2125-2134, 2008.
193. Ngo SN, Williams DB and Head RJ: Rosemary and cancer prevention: Preclinical perspectives. Crit Rev Food Sci Nutr 51:946-954, 2011.
194. Zick SM, Turgeon DK, Vareed SK, Ruffin MT, Litzinger AJ, Wright BD, Alrawi S, Normolle DP, Djuric Z and Brenner DE: Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev Res 4: 1929-1937, 2011.
195. Padma VV, Christie SAD and Ramkuma KM: Induction of apoptosis by ginger in HEp-2 cell line is mediated by reactive oxygen species. Basic Clin Pharmacol Toxicol 100: 302-307, 2007.
196. Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J and Liu JR: Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern Med 7: 44, 2007.
197. Hung JY, Hsu YL, Li CT, Ko YC, Ni WC, Huang MS and Kuo PL: 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small cell lung cancer A549 cells. J Agric Food Chem 57:9809-9816, 2009.
198. Amin A, Alkaabi A, Al-Falasi S and Daoud SA: Chemopreventive activities of Trigonella foenum graecum (Fenugreek) against breast cancer. Cell Biol Int 29: 687-694, 2005. (Pubitemid 41350751)
199. Khoja KK, Shaf G, Hasan TN, Syed NA, Al-Khalifa AS, Al-Assaf AH and Alshatwi AA: Fenugreek, a naturally occurring edible spice, kills MCF-7 human breast cancer cells via an apoptotic pathway. Asian Pac J Cancer Prev 12: 3299-3304, 2011.
200. Shabbeer S, Sobolewski M, Kachhap S, Davidson N, Carducci MA and Khan SR: Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer Biol Ther 8: 272-278, 2009.
201. Shaban A, Jahanmehr SA, Rezaeeian M, Einolahi N, Arjomand A, Monsefesfehani HR, Kazemi V and Akrami M: Fenugreek (Trigonella foenum graecum L.) seed extract induces cell death, growth inhibition and morphological change indicative of apoptosis in acute lymphoblastic leukemia. Res J Biol Sci 2:438-443, 2007.
202. Raju J, Patlolla JM, Swamy MV and Rao CV: Diosgenin, a steroid saponin of Trigonella foenum graecum (fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 13: 1392-1398, 2004. (Pubitemid 39071566)
203. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB and Liu M: Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and ERK signaling pathways. Mol Cancer Ther 7: 1789-1796, 2008.
204. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL and Tithof PK: In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22: 107-113, 2003.
205. Hassan SA, Ahmed WA, Galeb FM, El-Taweel MA and Abu-Bedair FA: In vitro challenge using thymoquinone on hepatocellular carcinoma (HepG2) cell line. Iran J Pharm Res 7:283-290, 2008.
206. Spindler SR: Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech Ageing Dev 126: 960-966, 2005.
207. de Jonge L, Moreira EAM, Martin CK and Ravussin E: Impact of six month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals. Obesity (Silver Spring) 18: 414-416, 2010.
208. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
209. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL and Bunin GR (eds.). NIH Pub. No. 99-4649, Bethesda, MD, U.S.A., 1999.
210. Raaschou-Nielsen O and Reynolds P: Air pollution and childhood cancer: A review of the epidemiological literature. Int J Cancer 118: 2920-2929, 2006.
211. Bunin GR, Kuijten RR, Buckley JD, Rorke LB and Meadows AT: Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 329: 536-541, 1993. (Pubitemid 23232622)
212. Orjuela MA, Titievsky L, Liu X, Ramirez-Ortiz M, Ponce-Castaneda V, Lecona E, Molina E, Beaverson K, Abramson DH and Mueller NE: Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. Cancer Epidemiol Biomarkers Prev 14: 1433-1440, 2005. (Pubitemid 40807342)
213. Martin RM, Gunnell D, Owen CG and Smith GD: Breastfeeding and childhood cancer: a systematic review with metaanalysis. Int J Cancer 117: 1020-1031, 2005. (Pubitemid 41688580)
214. Altinkaynak S, Selimoglu MA, Turgut A, Kilicaslan B and Ertekin V: Breast-feeding duration and childhood acute leukemia and lymphomas in a sample of Turkish children. J Pediatr Gastroenterol Nutr 42: 568-572, 2006. (Pubitemid 43804738)
215. Mathur GP, Gupta N, Mathur S, Gupta V, Pradhan S, Dwivedi JN, Tripathi BN, Kushwaha KP, Sathy N, Modi UJ, Shendurnikar N and Mishra PK: Breastfeeding and childhood cancer. Indian Pediatr 30: 651-657, 1993.
216. Dietz WH: Childhood weight affects adult morbidity and mortality. J Nutr 128: 411S-414S, 1998.